Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,581 | 1,818 | 200 | N/A | N/A |
| TOTAL | $19,338 | $1,819 | $209 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 34,244 | 19,003 | N/A | N/A | N/A |
| Intangibles | 14,869 | 7,918 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 434 | 0 | 0 | 0 |
| TOTAL | $49,113 | $27,356 | $N/A | $N/A | $N/A |
| Total Assets | $68,451 | $29,175 | $209 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 58 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 642 | 523 | 0 | 0 | 0 |
| Accrued Expenses | 2,868 | 815 | 190 | N/A | N/A |
| Other current liabilities | N/A | 10 | N/A | N/A | N/A |
| TOTAL | $3,510 | $1,407 | $190 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 8 | 0 | 0 | 0 | 0 |
| TOTAL | $13,442 | $7,589 | $N/A | $N/A | $N/A |
| Total Liabilities | $16,951 | $8,995 | $190 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,090 | N/A | N/A | N/A | N/A |
| Common Shares | 2 | 1 | 0 | N/A | N/A |
| Retained earnings | -74,731 | -17,830 | -14,568 | N/A | N/A |
| TOTAL | $51,500 | $20,180 | $19 | $N/A | $N/A |
| Total Liabilities And Equity | $68,451 | $29,175 | $209 | $0 | $0 |